Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene

Zongmeng Zhang, Jie Chen, Fanghui Chen, Daolun Yu, Rui Li, Chenglong Lv, Haosen Wang, Honglin Li, Jun Li, Yafei Cai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Spinal cord injury (SCI) is generally divided into primary and secondary injuries, and apoptosis is an important event of the secondary injury. As an endogenous bile acid and recognized endoplasmic reticulum (ER) stress inhibitor, tauroursodeoxycholic acid (TUDCA) administration has been reported to have a potentially therapeutic effect on neurodegenerative diseases, but its real mechanism is still unclear. In this study, we evaluated whether TUDCA could alleviate traumatic damage of the spinal cord and improve locomotion function in a mouse model of SCI. Traumatic SCI mice were intraperitoneally injected with TUDCA, and the effects were evaluated based on motor function assessment, histopathology, apoptosis detection, qRT-PCR, and western blot at different time periods. TUDCA administration can improve motor function and reduce secondary injury and lesion area after SCI. Furthermore, the apoptotic ratios were significantly reduced; Grp78, Erdj4, and CHOP were attenuated by the treatment. Unexpectedly, the levels of CIBZ, a novel therapeutic target for SCI, were specifically up-regulated. Taken together, it is suggested that TUDCA effectively suppressed ER stress through targeted up-regulation of CIBZ. This study also provides a new strategy for relieving secondary damage by inhibiting apoptosis in the early treatment of spinal cord injury.

Original languageEnglish (US)
Pages (from-to)551-560
Number of pages10
JournalCell Stress and Chaperones
Volume23
Issue number4
DOIs
StatePublished - Jul 1 2018

Fingerprint

Spinal Cord Injuries
Up-Regulation
Genes
Endoplasmic Reticulum Stress
Apoptosis
Wounds and Injuries
Neurodegenerative diseases
Therapeutic Uses
Locomotion
Bile Acids and Salts
Neurodegenerative Diseases
tauroursodeoxycholic acid
Spinal Cord
Western Blotting
Polymerase Chain Reaction

Keywords

  • Apoptosis
  • CIBZ
  • ER stress
  • Spinal cord injury
  • Tauroursodeoxycholic acid

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene. / Zhang, Zongmeng; Chen, Jie; Chen, Fanghui; Yu, Daolun; Li, Rui; Lv, Chenglong; Wang, Haosen; Li, Honglin; Li, Jun; Cai, Yafei.

In: Cell Stress and Chaperones, Vol. 23, No. 4, 01.07.2018, p. 551-560.

Research output: Contribution to journalArticle

Zhang, Zongmeng ; Chen, Jie ; Chen, Fanghui ; Yu, Daolun ; Li, Rui ; Lv, Chenglong ; Wang, Haosen ; Li, Honglin ; Li, Jun ; Cai, Yafei. / Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene. In: Cell Stress and Chaperones. 2018 ; Vol. 23, No. 4. pp. 551-560.
@article{ac23e847ec7c47e08c6f7f2eab0b30b7,
title = "Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene",
abstract = "Spinal cord injury (SCI) is generally divided into primary and secondary injuries, and apoptosis is an important event of the secondary injury. As an endogenous bile acid and recognized endoplasmic reticulum (ER) stress inhibitor, tauroursodeoxycholic acid (TUDCA) administration has been reported to have a potentially therapeutic effect on neurodegenerative diseases, but its real mechanism is still unclear. In this study, we evaluated whether TUDCA could alleviate traumatic damage of the spinal cord and improve locomotion function in a mouse model of SCI. Traumatic SCI mice were intraperitoneally injected with TUDCA, and the effects were evaluated based on motor function assessment, histopathology, apoptosis detection, qRT-PCR, and western blot at different time periods. TUDCA administration can improve motor function and reduce secondary injury and lesion area after SCI. Furthermore, the apoptotic ratios were significantly reduced; Grp78, Erdj4, and CHOP were attenuated by the treatment. Unexpectedly, the levels of CIBZ, a novel therapeutic target for SCI, were specifically up-regulated. Taken together, it is suggested that TUDCA effectively suppressed ER stress through targeted up-regulation of CIBZ. This study also provides a new strategy for relieving secondary damage by inhibiting apoptosis in the early treatment of spinal cord injury.",
keywords = "Apoptosis, CIBZ, ER stress, Spinal cord injury, Tauroursodeoxycholic acid",
author = "Zongmeng Zhang and Jie Chen and Fanghui Chen and Daolun Yu and Rui Li and Chenglong Lv and Haosen Wang and Honglin Li and Jun Li and Yafei Cai",
year = "2018",
month = "7",
day = "1",
doi = "10.1007/s12192-017-0862-1",
language = "English (US)",
volume = "23",
pages = "551--560",
journal = "Cell Stress and Chaperones",
issn = "1355-8145",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene

AU - Zhang, Zongmeng

AU - Chen, Jie

AU - Chen, Fanghui

AU - Yu, Daolun

AU - Li, Rui

AU - Lv, Chenglong

AU - Wang, Haosen

AU - Li, Honglin

AU - Li, Jun

AU - Cai, Yafei

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Spinal cord injury (SCI) is generally divided into primary and secondary injuries, and apoptosis is an important event of the secondary injury. As an endogenous bile acid and recognized endoplasmic reticulum (ER) stress inhibitor, tauroursodeoxycholic acid (TUDCA) administration has been reported to have a potentially therapeutic effect on neurodegenerative diseases, but its real mechanism is still unclear. In this study, we evaluated whether TUDCA could alleviate traumatic damage of the spinal cord and improve locomotion function in a mouse model of SCI. Traumatic SCI mice were intraperitoneally injected with TUDCA, and the effects were evaluated based on motor function assessment, histopathology, apoptosis detection, qRT-PCR, and western blot at different time periods. TUDCA administration can improve motor function and reduce secondary injury and lesion area after SCI. Furthermore, the apoptotic ratios were significantly reduced; Grp78, Erdj4, and CHOP were attenuated by the treatment. Unexpectedly, the levels of CIBZ, a novel therapeutic target for SCI, were specifically up-regulated. Taken together, it is suggested that TUDCA effectively suppressed ER stress through targeted up-regulation of CIBZ. This study also provides a new strategy for relieving secondary damage by inhibiting apoptosis in the early treatment of spinal cord injury.

AB - Spinal cord injury (SCI) is generally divided into primary and secondary injuries, and apoptosis is an important event of the secondary injury. As an endogenous bile acid and recognized endoplasmic reticulum (ER) stress inhibitor, tauroursodeoxycholic acid (TUDCA) administration has been reported to have a potentially therapeutic effect on neurodegenerative diseases, but its real mechanism is still unclear. In this study, we evaluated whether TUDCA could alleviate traumatic damage of the spinal cord and improve locomotion function in a mouse model of SCI. Traumatic SCI mice were intraperitoneally injected with TUDCA, and the effects were evaluated based on motor function assessment, histopathology, apoptosis detection, qRT-PCR, and western blot at different time periods. TUDCA administration can improve motor function and reduce secondary injury and lesion area after SCI. Furthermore, the apoptotic ratios were significantly reduced; Grp78, Erdj4, and CHOP were attenuated by the treatment. Unexpectedly, the levels of CIBZ, a novel therapeutic target for SCI, were specifically up-regulated. Taken together, it is suggested that TUDCA effectively suppressed ER stress through targeted up-regulation of CIBZ. This study also provides a new strategy for relieving secondary damage by inhibiting apoptosis in the early treatment of spinal cord injury.

KW - Apoptosis

KW - CIBZ

KW - ER stress

KW - Spinal cord injury

KW - Tauroursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=85034229945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034229945&partnerID=8YFLogxK

U2 - 10.1007/s12192-017-0862-1

DO - 10.1007/s12192-017-0862-1

M3 - Article

C2 - 29151236

AN - SCOPUS:85034229945

VL - 23

SP - 551

EP - 560

JO - Cell Stress and Chaperones

JF - Cell Stress and Chaperones

SN - 1355-8145

IS - 4

ER -